The aim of this study was to assess the prevalence of gastro-oesophageal reflux disease (GORD) symptoms and tooth wear in patients with Sjögren’s syndrome (SS) compared with matched controls. GORD symptoms were assessed for 33 SS patients and 20 age- and sex-matched controls. Tooth wear was assessed in all patients and controls. The results were further analysed in two subgroups of SS patients and controls with and without GORD symptoms (SS patients without GORD symptoms: n = 11, controls without GORD symptoms: n = 18). A higher proportion of SS patients reported suffering from heartburn and regurgitation than controls (p < 0.001 and p = 0.02, respectively). SS patients without GORD symptoms had a statistically significantly higher percentage of surfaces with tooth wear affecting dentine than controls (p < 0.001).

Keywords:
Dental erosion, Gastro-oesophageal reflux disease, Saliva, Sjögrenߣs syndrome, Tooth wear
1.
Bartlett DW, Evans DF, Anggiansah A, Smith BGN: A study of the association between gastro-oesophageal reflux and palatal dental erosion. Br Dent J 1996;181:125–132.
2.
Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ: An evidence-based appraisal of reflux disease management – The Genval Workshop Report. Gut 1999;44 (suppl 2):S1–S16.
3.
Holbrook WP, Furuholm J, Gudmundsson K, Theodors A, Meurman JH: Gastric reflux is a significant causative factor of tooth erosion. J Dent Res 2009;88:422–426.
4.
Järvinen VK, Rytoma II, Heinonen OP: Risk factors in dental erosion. J Dent Res 1991;70:942–947.
5.
Jensdottir T, Nauntofte B, Buchwald C, Bardow A: Effect of sucking acidic candy on whole-mouth saliva composition. Caries Res 2005;39:468–474.
6.
Kjellén G, Fransson SG, Lindström F, Sökjer H, Tibbling L: Oesophageal function, radiography and dysphagia in Sjögren’s syndrome. Dig Dis Sci 1986;31:225–229.
7.
Klauser AG, Schindlbeck NE, Muller-Lissner SA: Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335:205–208.
8.
Lussi A: Dental erosion: clinical diagnosis and case history taking. Eur J Oral Sci 1996;104:191–198.
9.
Mandl T, Ekberg O, Wollmer P, Manthorpe R, Jacobsson LT: Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren’s Syndrome. Scand J Rheumatol 2007;36:394–401.
10.
Moazzez R, Bartlett DW, Anggiansah A: Dental erosion, gastro-oesophageal reflux disease and saliva: how are they related? J Dent 2004;32:489–494.
11.
Mohammed I, Nightingale P, Trudgill NJ: Risk factors for gastro-oesophageal reflux disease symptoms: a community study. Aliment Pharmacol Ther 2005;21:821–827.
12.
Ogut F, Midilli R, Oder G, Engin EZ, Karci B, Kabasakal Y: Laryngeal findings and voice quality in Sjögren’s syndrome. Auris Nasus Larynx 2005;32:375–380.
13.
Pace F, Pallota S, Tonini M, Vakil N, Bianchi Porro G: Systematic review: gastro-oesophageal reflux disease and dental lesions. Aliment Pharmacol Ther 2008;27:1179–1186.
14.
Piangprach T, Hengtrakool C, Kukiattrakoon B, Kedjarune-Leggat U: The effect salivary factors on dental erosion in various age groups and tooth surfaces. J Am Dent Assoc 2009;140:1137–1143.
15.
Smith BGN, Knight JK: An index for measuring the wear of teeth. Br Dent J 1984;156:435–438.
16.
Sreebny LM: Saliva in health and disease: an appraisal and update. Int Dent J 2000;50:140–161.
17.
Volter F, Fain O, Mathieu E, Thomas M: Oesophageal function and Sjögren’s syndrome. Dig Dis Sci 2004;49:248–253.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.